Type 1 diabetes research watch: recent papers and DOI records worth sorting
A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.
The evidence posture
Research records are not all equal. A PubMed or DOI record may represent a clinical study, review, device paper, mechanistic finding, animal study, or early-stage idea. The job of this page is to surface the source and keep the evidence label visible.
The highest-value Type 1 diabetes watch topics include beta-cell replacement, islet biology, immune modulation, automated insulin delivery, CGM performance, hypoglycemia, pediatric care, and quality-of-life outcomes.
Recent research records
- Human and mouse regenerative macrophages enhance beta cell survival, function, and proliferation. — Islets. Authors: Monajemi M, Craciun AS, Huang Q. Journal ArticleSource
- Is the intraportal or renal subcapsular space a preferable site for islet allo- and xeno-transplantation? A brief historical review. — Islets. Authors: De Taeye S, Bottino R, Cooper DKC. Journal Article, Review, Historical ArticleSource
- MLPH/RAB3A accelerates the differentiation of pancreatic stem cells to islet β-cells to control blood glucose in diabetic rats. — Organogenesis. Authors: Shan J, Wang H, Zhu G. Journal ArticleSource
- Role of small intronic RNAs in the crosstalk between immune cells and β-cells during type 1 diabetes development. — RNA biology. Authors: Poddar S, Brozzi F, Cosentino C. Journal ArticleSource
- Co-transplantation of pancreatic islets with adipose-derived mesenchymal stem cells in vascularized kidney ECM scaffolds to restore type 1 diabetes mellitus. — Bioactive materials. Authors: Choi M, Shanto PC, Fahad MAA. Journal ArticleSource
- Metabolic Programming of β-Cell Fate, State, and Function through Time and Space. — Physiology (Bethesda, Md.). Authors: MacDonald TL, Bonner-Weir S. Journal Article, ReviewSource
- A physiologically based mathematical model describing estradiol and progesterone actions on glucose-insulin dynamics throughout the menstrual cycle. — Journal of theoretical biology. Authors: Ramírez Mazo C, Gómez-Echavarría L, Lema-Pérez L. Journal ArticleSource
- GLP1-E2 therapy delays autoimmune diabetes in late-stage prediabetic NOD mice and potentiates low-dose anti-CD3 therapy for enhanced disease protection. — Diabetologia. Authors: Degroote L, Chrzanowski J, Lemaitre P. Journal ArticleSource
- The evolution of CAR therapies across oncology and autoimmunity: mechanistic insights and therapeutic innovations. — International immunopharmacology. Authors: Abd El-Fattah EE, Hamdy R, Soliman SSM. Journal Article, ReviewSource
What needs editorial review
- Whether the record is human clinical evidence, preclinical work, review material, device performance data, or commentary.
- Whether outcomes matter to families: A1C, time in range, severe hypoglycemia, DKA, sleep, school, sports, treatment burden, and durability.
- Whether a company, sponsor, or press release is driving the claim before independent evidence exists.
This article is an evidence-labeled information brief, not medical advice. Use the linked source records and your care team before making treatment decisions.